Immucell ICCC
NASDAQ ICCC
$10.06 -0.03 (-0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

Immucell (ICCC) Change in Acquisitions & Divestments (2010 - 2020)

Immucell's (ICCC) quarterly Change in Acquisitions & Divestments came in at $2.0 million in Q1 2020, down 73.52% on a QoQ basis from $7.4 million in Q4 2019.

Immucell (ICCC) Change in Acquisitions & Divestments (2010 - 2020) Analysis & Trends

Immucell (ICCC) has 10 years of Change in Acquisitions & Divestments data on file, last reported at $2.0 million in Q1 2020.

  • Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $2.0 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $9.4 million (changed N/A YoY) and the FY2019 annual result came in at $7.7 million, up 2968.0% from the prior year.
  • Change in Acquisitions & Divestments slipped to $2.0 million in Q1 2020, from $7.4 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $7.4 million in Q4 2019 to a low of $487000.0 in Q3 2017.
  • A 4-year average of $2.2 million and a median of $2.0 million in 2020 frame the typical range for Change in Acquisitions & Divestments.
  • Annual changes were most pronounced in 2016 — Change in Acquisitions & Divestments jumped 700.0% — and 2017, when it plunged 75.45%.
  • Tracing ICCC's Change in Acquisitions & Divestments over 4 years: stood at $496000.0 in 2016, then declined by 1.81% to $487000.0 in 2017, then soared by 1423.61% to $7.4 million in 2019, then sank by 73.52% to $2.0 million in 2020.
  • The last three Change in Acquisitions & Divestments figures came in at $2.0 million (Q1 2020), $7.4 million (Q4 2019), and $487000.0 (Q3 2017), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Immucell 91.19 Mn 82.33 Mn 2.44 Mn

Historic Data

Download Data
DateValue
Mar 31, 2020 1.97 Mn
Mar 31, 2020 1.97 Mn
Dec 31, 2019 7.42 Mn
Dec 31, 2019 7.42 Mn
Sep 30, 2017 487,000.00
Sep 30, 2017 487,000.00
Jun 30, 2017 2.48 Mn
Jun 30, 2017 2.48 Mn
Mar 31, 2017 2.73 Mn
Mar 31, 2017 2.73 Mn
Dec 31, 2016 496,000.00
Dec 31, 2016 496,000.00
Sep 30, 2016 1.98 Mn
Sep 30, 2016 1.98 Mn
Jun 30, 2016 1.49 Mn
Jun 30, 2016 1.49 Mn
Mar 31, 2016 496,000.00
Mar 31, 2016 496,000.00
Sep 30, 2015 248,000.00
Sep 30, 2015 248,000.00